KR880701560A - 개선된 백신 및 제조방법 - Google Patents

개선된 백신 및 제조방법

Info

Publication number
KR880701560A
KR880701560A KR1019880700567A KR880700567A KR880701560A KR 880701560 A KR880701560 A KR 880701560A KR 1019880700567 A KR1019880700567 A KR 1019880700567A KR 880700567 A KR880700567 A KR 880700567A KR 880701560 A KR880701560 A KR 880701560A
Authority
KR
South Korea
Prior art keywords
manufacturing
improved vaccine
vaccine
improved
Prior art date
Application number
KR1019880700567A
Other languages
English (en)
Other versions
KR920002165B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR880701560A publication Critical patent/KR880701560A/ko
Application granted granted Critical
Publication of KR920002165B1 publication Critical patent/KR920002165B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6068Other bacterial proteins, e.g. OMP
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
KR1019880700567A 1986-09-22 1987-08-19 개선된 백신 및 제조방법 KR920002165B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US909,964 1986-09-22
US7518787A 1987-07-16 1987-07-16
US075,187 1987-07-16
PCT/US1987/002056 WO1988001873A1 (en) 1986-09-22 1987-08-19 Vaccine and method of preparation

Publications (2)

Publication Number Publication Date
KR880701560A true KR880701560A (ko) 1988-11-03
KR920002165B1 KR920002165B1 (ko) 1992-03-19

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700567A KR920002165B1 (ko) 1986-09-22 1987-08-19 개선된 백신 및 제조방법

Country Status (17)

Country Link
EP (1) EP0283505B1 (ko)
JP (1) JPH01501064A (ko)
KR (1) KR920002165B1 (ko)
CN (1) CN1030019A (ko)
AP (1) AP8700068A0 (ko)
AT (1) ATE108067T1 (ko)
BR (1) BR8707471A (ko)
CA (1) CA1322721C (ko)
DE (1) DE3750176T2 (ko)
DK (1) DK272688A (ko)
ES (1) ES2007720A6 (ko)
FI (1) FI882397A0 (ko)
GR (1) GR871460B (ko)
IL (1) IL83953A (ko)
NZ (2) NZ221868A (ko)
PT (1) PT85760B (ko)
WO (1) WO1988001873A1 (ko)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052674T3 (es) * 1987-11-03 1994-07-16 Syntex Inc Adyuvante de vacunas.
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
EP1278542A2 (en) 2000-05-05 2003-01-29 Cytos Biotechnology AG Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7264810B2 (en) 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
RU2324704C2 (ru) 2002-07-17 2008-05-20 Цитос Байотекнолоджи Аг Молекулярные массивы антигенов
JP5084103B2 (ja) 2002-07-18 2012-11-28 サイトス バイオテクノロジー アーゲー ハプテン担体抱合体およびその用法
EP2338510A1 (en) 2002-07-19 2011-06-29 Novartis Pharma AG Vaccine compositions containing amyloid beta1-6 antigen arrays
US20060257415A1 (en) * 2002-09-03 2006-11-16 Fondation Eurov Acc Adjuvants
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
EP1991264B1 (en) 2006-03-07 2015-01-07 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
WO2009091692A2 (en) * 2008-01-18 2009-07-23 Aeras Global Tb Vaccine Foundation Malaria vaccine compositions and constituents which elicit cell mediated immunity
ES2594102T3 (es) 2008-04-18 2016-12-15 Vaxinnate Corporation Mutantes por deleción de la flagelina y métodos para su uso
WO2011028875A1 (en) * 2009-09-03 2011-03-10 Wake Forest University Health Sciences Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production
JPS56500298A (ko) * 1979-03-27 1981-03-12
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
EP0283505B1 (en) 1994-07-06
PT85760B (pt) 1990-08-31
IL83953A (en) 1992-05-25
WO1988001873A1 (en) 1988-03-24
PT85760A (en) 1987-10-01
AU613588B2 (en) 1991-08-08
ES2007720A6 (es) 1989-07-01
AU7113191A (en) 1991-07-11
EP0283505A1 (en) 1988-09-28
CN1030019A (zh) 1989-01-04
KR920002165B1 (ko) 1992-03-19
IL83953A0 (en) 1988-02-29
BR8707471A (pt) 1988-09-13
JPH01501064A (ja) 1989-04-13
FI882397A (fi) 1988-05-20
FI882397A0 (fi) 1988-05-20
NZ221868A (en) 1991-03-26
AP8700068A0 (en) 1989-03-21
ATE108067T1 (de) 1994-07-15
AU8023287A (en) 1988-04-07
CA1322721C (en) 1993-10-05
EP0283505A4 (en) 1989-11-07
AU629103B2 (en) 1992-09-24
DE3750176D1 (de) 1994-08-11
NZ236829A (en) 1993-07-27
DK272688A (da) 1988-07-12
DE3750176T2 (de) 1994-10-13
GR871460B (en) 1988-03-21
DK272688D0 (da) 1988-05-18

Similar Documents

Publication Publication Date Title
KR880701560A (ko) 개선된 백신 및 제조방법
IT1205010B (it) Tetraidronaftalin-derivati e indan-derivati
KR890016266A (ko) 전주 및 그 제조방법과 전주조립체
DE3752263D1 (de) Impfstoffe
KR890010464A (ko) 풀리 및 그 제조방법
DK213987D0 (da) Immunogen
KR880701639A (ko) 화장판 및 그의 제법
KR860005526A (ko) 관통 캐패시터 장치 및 그 제조방법
KR890700300A (ko) 제어유닛 및 그 제조방법
KR860005810A (ko) 4h-1-벤조피란-4-온 및 그 제조방법
KR880701621A (ko) 벨트 및 그 제조방법
KR880701813A (ko) 캠축 및 캠축 제조방법
KR890004398A (ko) 반도체장치 및 그의 제조방법
DE3855494T2 (de) Abfragevorrichtung und -methode
KR860005765A (ko) 강인성 세라믹스 및 그 제조방법
KR890700356A (ko) 신규의 백신
DK413187D0 (da) Semicarbazoner og thiosemicarbazoner
KR880004732A (ko) 본딩방법
FI871131A (fi) Menetelmä rokotteen valmistamiseksi
KR900004691A (ko) 페닐피리딘 및 이의 제조방법
DK375488D0 (da) Vaccine
KR870004977A (ko) 2,2'-바이-1h-이미다졸 및 그의 제조방법
KR870010952A (ko) 포장체 및 그의 제조방법
DK286087A (da) Vaccinefremstilling
FR2606817B1 (fr) Cloture

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee